Testosterone concentrations in men on chronic glucocorticosteroid therapy

J R Coll Physicians Lond. 1997 Mar-Apr;31(2):168-70.

Abstract

To determine whether free (or active) testosterone concentrations are reduced in men receiving glucocorticosteroids for chronic inflammatory diseases, 17 men (mean age 55.5 years) receiving a mean daily dose of 16.3 mg prednisolone, and 13 control patients (mean age 52.2 years) receiving no prednisolone, were studied. Serum testosterone and the testosterone/sex hormone binding globulin (SHBG) ratio were measured. The testosterone/SHBG ratio (a measure of free (active) testosterone) was significantly reduced in patients treated with prednisolone (p = 0.026), thus showing that glucocorticosteroids reduce free testosterone in male patients. This may be an important cause of glucocorticosteroid-induced osteoporosis, and suggests an additional approach to bone prophylaxis and treatment.

MeSH terms

  • Anti-Inflammatory Agents / adverse effects*
  • Bone Density
  • Case-Control Studies
  • Humans
  • Male
  • Middle Aged
  • Osteoporosis / chemically induced
  • Prednisolone / adverse effects*
  • Sex Hormone-Binding Globulin / analysis*
  • Testosterone / blood*

Substances

  • Anti-Inflammatory Agents
  • Sex Hormone-Binding Globulin
  • Testosterone
  • Prednisolone